In Brief

Vitamin Shoppe buys Super Supplements; investor Ackman wages war on Herbalife; NPA cancels MarketPlace show; Herbalife acquires N.C. facility; Capsugel expands quality control; AHP releases aloe vera monograph standard: more news In Brief.

[Vitamin Shoppe Inc.] expands its foothold in the Pacific Northwest U.S. with the acquisition of Seattle-based Super Supplements Inc. for $50 million, the North Bergen, N.J., based firm announced Dec. 17. The deal, which is expected to close Dec. 31 pending customary closing conditions, adds 31 stores to Vitamin Shoppe’s existing 17 stores in Washington, Oregon and Idaho. Vitamin Shoppe expects the deal will contribute $75 million in revenue in 2013 and a neutral or slightly positive impact on earnings per share.

Herbalife Ltd. fights activist investor William Ackman’s allegations that it operates an illegal pyramid scheme with its independent distributors....

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

Ocaliva: Still No Clarity On Why EU Court Opposed Revocation Of Approval

 

Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.

Final Chance To Have Your Say: Take Our Reader Survey This Week

 
• By 

This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.

Shape Our Content: Take The Reader Survey

 
• By 

We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.

Brazil Pilots Digital Drug Pack Inserts

 

A new pilot aims to take Brazil closer to ‘digital transformation.’

More from Pink Sheet

‘Prices Can Remain Contaminated Indefinitely’: Advanz Brushed Aside On UK Liothyronine Appeal

 
• By 

England’s Court of Appeal has upheld a Competition Appeal Tribunal’s 2023 finding that Advanz and its former owner Cinven abused their dominant position in the UK market for liothyronine tablets by charging prices that were many orders of magnitude higher than the benchmark for fair pricing.

New EU Filings

 

Linerixibat, GSK's treatment for cholestatic pruritus in patients with primary biliary cholangitis, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.

Podium Policy Returns To US FDA, Or Is It Podcast Policy?

 

US FDA critics have long decried the practice of using informal communications to convey regulatory expectations as podium policy. In the Makary era, the phrase may need to be updated because the agency now seems to be specializing in policy by podcast.